Personalized prediction of overall survival in patients with AML in non-complete remission undergoing allo-HCT.
Hirabayashi S, Uozumi R, Kondo T, Arai Y, Kawata T, Uchida N, Marumo A, Ikegame K, Fukuda T, Eto T, Tanaka M, Wake A, Kanda J, Kimura T, Tabuchi K, Ichinohe T, Atsuta Y, Yanada M, Yano S.
Hirabayashi S, et al. Among authors: uozumi r.
Cancer Med. 2021 Jul;10(13):4250-4268. doi: 10.1002/cam4.3920. Epub 2021 Jun 16.
Cancer Med. 2021.
PMID: 34132501
Free PMC article.